Cyclerion Therapeutics, Inc. Gains 44.55%
Wed, Feb 19, 2020 at 05:30 PM
Cyclerion Therapeutics, Inc. (CYCN:NASDAQ) jumped higher at $5.84, a gain of 44.6%. From Tue 28 Jan 20, the stock recorded 50.00% Up Days and 46.67% Green Days
The share price of the company has been moving sideways in recent weeks.
About Cyclerion Therapeutics, Inc. (CYCN:NASDAQ)
Cyclerion Therapeutics Inc is a clinical-stage biopharmaceutical company harnessing the power of soluble guanylate cyclase (sGC) pharmacology to discover, develop and commercialize breakthrough treatments for serious and orphan diseases.Its focus is on enabling the full therapeutic potential of next-generation sGC stimulators.
Top 10 Gainers:
- Zomedica Pharmaceuticals Corp. (ZOM:NYSEMKT), 79.64%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 44.55%
- Myomo, Inc. (MYO:NYSEMKT), 43.41%
- Enphase Energy, Inc. (ENPH:NASDAQ), 42.44%
- ShotSpotter, Inc. (SSTI:NASDAQ), 32.56%
- Viveve Medical, Inc. (VIVE:NASDAQ), 32.35%
- Can-Fite BioPharma Ltd. (CANF:NYSEMKT), 30.43%
- Altisource Asset Management Corporation (AAMC:NYSEMKT), 30.4%
- LMP Automotive Holdings, Inc. (LMPX:NASDAQ), 28.41%
- Arcus Biosciences, Inc. (RCUS:NYSE), 26.63%